Report a data issue, formatting problem, or request follow-up. Our team responds within one business day.
Be the first to review this report.
Gaprin is a full-fledged microbiological protein, which is a biomass of inactivated cells of non-pathogenic methanotrophic bacteria and is intended for use as the main functional component of compound feeds and protein-vitamin supplements (BVD). Thanks to it, it is possible to produce complete, balanced compound feeds that ensure the intensive development of animal husbandry, poultry and fish farming. Gaprin contains: crude protein 70-79%. According to its composition, gaprin is a complete protein product with a high content of B vitamins (especially B12), amino acids and microelements, which fully meets the needs of animals of various groups and ages. In addition, in comparison with protein feeds of plant origin (including cereals and legumes, including soybeans), gaprin provides balanced amino acid nutrition for animals, primarily in terms of lysine, serine and methionine. Gaprin was produced from 1985 to 1994 at a pilot plant at the Svetlo-Yarsk BVK plant in the Volgograd region of CIS. Of the 40 thousand tons of haprin produced during the specified period, most of it was exported. However, in 1994 this production was closed. The bioprotein gaprin can also be produced from associated petroleum gas (APG), which is still flared in refineries and oil fields, including offshore oil platforms, as well as from methane from mines, coal seams and from methane biogas from waste processing.
Global Gaprin key players include Unibio, Calysta, Prtotelux, Metanica, Giprobiosyntez, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 50%, followed by Europe and North America, both have a share about 38% percent. In terms of product, Feed Grade Gaprin is the largest segment, with a share over 70%. And in terms of Application, the largest level is Animal Feed, followed by Food & Beverages, etc.
This report presents an overview of global market for Gaprin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Gaprin, also provides the sales of main regions and countries. Of the upcoming market potential for Gaprin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gaprin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gaprin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gaprin sales, projected growth trends, production technology, application and end-user industry.
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Gaprin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Gaprin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gaprin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
You may also be interested in
